Trademark: 88366693
Word
HETLIOZ (TASIMELTEON) CAPSULES
Status
Registered
Status Code
700
Status Date
Tuesday, April 28, 2020
Serial Number
88366693
Registration Number
6040230
Registration Date
Tuesday, April 28, 2020
Mark Type
3000
Filing Date
Monday, April 1, 2019
Published for Opposition
Tuesday, July 16, 2019

Trademark Owner History
Vanda Pharmaceuticals Inc. - Original Registrant

Classifications
5 Pharmaceutical preparations, containing tasimelteon, for use in the treatment of circadian rhythm diseases and disorders; and pharmaceutical preparations, containing tasimelteon, for use in the treatment of non-24 hour sleep-wake disorder
Color is not claimed as a feature of the mark.
"TASIMELTEON CAPSULES"
The mark consists of the word "HETLIOZ" on a first line, and "(TASIMELTEON) CAPSULES" on a second line, with an arc of eleven solid circles of increasing size connecting the first and second lines of text.

Trademark Events
Apr 28, 2020
Registered-Principal Register
Mar 25, 2020
1(B) Basis Deleted; Proceed To Registration
Mar 3, 2020
Notice Of Allowance Cancelled
Mar 25, 2020
Case Assigned To Intent To Use Paralegal
Mar 3, 2020
Teas Post Publication Amendment Received
Sep 10, 2019
Noa E-Mailed - Sou Required From Applicant
Jul 16, 2019
Official Gazette Publication Confirmation E-Mailed
Jul 16, 2019
Published For Opposition
Jun 26, 2019
Notification Of Notice Of Publication E-Mailed
Jun 12, 2019
Approved For Pub - Principal Register
Jun 11, 2019
Assigned To Examiner
Apr 20, 2019
Notice Of Design Search Code E-Mailed
Apr 19, 2019
New Application Office Supplied Data Entered In Tram
Apr 4, 2019
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24